相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of Anti-inflammatory Activity of 3-Acetylmyricadiol in LPS-Stimulated Raw 264.7 Macrophages
Gazanfar Ahmad et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2022)
Modulation of proteasome activity by curcumin and didemethylcurcumin
Tapan K. Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Review on marine sponge alkaloid, aaptamine: A potential antibacterial and anticancer drug
Vinita Manimaran Nadar et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2022)
Ubiquitin Proteasome System Activity is Suppressed by Curcumin following Exercise-Induced Muscle Damage in Human Skeletal Muscle
Thomas D. Cardaci et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Design, Synthesis, Molecular Modelling, and Biological Evaluation of Oleanolic Acid-Arylidene Derivatives as Potential Anti-Inflammatory Agents
Reyaz Hassan Mir et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
β-Lactone Derivatives and Their Anticancer Activities: A Short Review
Jun Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Curcumin prevents obesity by targeting TRAF4-induced ubiquitylation in m6A-dependent manner
Yushi Chen et al.
EMBO REPORTS (2021)
Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
Shansa Pranami E. Jayaweera et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer Therapy
Xin Chen et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
Ramon Yarza et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer
Jerry Vriend et al.
CANCERS (2021)
Marine-derived pipeline anticancer natural products: a review of their pharmacotherapeutic potential and molecular mechanisms
Mohamed Ali Seyed et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Importance of ethnopharmacological studies in drug discovery: role of medicinal plants
Ipek Suntar
PHYTOCHEMISTRY REVIEWS (2020)
Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification
Jun Wan Shin et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Effect of Curcumin on Protein Damage Induced by Rotenone in Dopaminergic PC12 Cells
Sandra Buratta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy
Desong Kong et al.
REDOX BIOLOGY (2020)
Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets
Lik Tong Tan et al.
MOLECULES (2020)
Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4
Ismael Obaidi et al.
BIOLOGY-BASEL (2020)
Ubiquitin-proteasome system (UPS) as a target for anticancer treatment
Jinyoung Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis
Le Liu et al.
PHYTOMEDICINE (2020)
Curcumin Down-Regulates Toll-Like Receptor-2 Gene Expression and Function in Human Cystic Fibrosis Bronchial Epithelial Cells
Niraj Chaudhary et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system
Aleksandra Golonko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery
Fernanda Majolo et al.
PHYTOCHEMISTRY LETTERS (2019)
Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
Alexey Morozov et al.
FRONTIERS IN ONCOLOGY (2019)
Epigallocatechin-3-gallate (EGCG) inhibits aggregation of pulmonary fibrosis associated mutant surfactant protein A2 via a proteasomal degradation pathway
Yingyi Quan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Ixazomib - the first oral proteasome inhibitor
Jingmei Xie et al.
LEUKEMIA & LYMPHOMA (2019)
Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL
Hang Thi Thuy Bui et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells
Bor-Ren Huang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Modulation of the Proteasome Pathway by Nano-Curcumin and Curcumin in Retinal Pigment Epithelial Cells
J. Emanuel Ramos de Carvalho et al.
OPHTHALMIC RESEARCH (2018)
Syringic acid prevents skin carcinogenesis via regulation of NoX and EGFR signaling
Su Jeong Ha et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials
Seyed Fazel Nabavi et al.
CANCER LETTERS (2018)
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Nicholas Ekow Thomford et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2
Sourav Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Emerging Cancer Therapeutic Targets in Protein Homeostasis
Prabhakar Bastola et al.
AAPS JOURNAL (2018)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
Mahmoud Hashemzaei et al.
ONCOLOGY REPORTS (2017)
Recent Patents on Proteasome Inhibitors of Natural Origin
Daniela Correia da Silva et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2017)
Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling
Bing Han et al.
ONCOTARGET (2017)
NOX4-mediated ROS production induces apoptotic cell death via down-regulation of c-FLIP and Mcl-1 expression in combined treatment with thioridazine and curcumin
Seung Un Seo et al.
REDOX BIOLOGY (2017)
Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer
Wei Qiu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing
Claire L. Soave et al.
CANCER AND METASTASIS REVIEWS (2017)
Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase
Xin Yue et al.
BIOCHEMICAL PHARMACOLOGY (2017)
ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer
Kiran Mahajan et al.
CANCER CELL (2017)
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor
Cristina Andreani et al.
AGING-US (2017)
Marizomib for central nervous system-multiple myeloma
Ashraf Badros et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Kaijun Di et al.
NEURO-ONCOLOGY (2016)
Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome
Yujiao He et al.
ONCOTARGET (2016)
Gallic acid induces apoptosis in EGFR-mutant non-small cell lung cancers by accelerating EGFR turnover
Boas Nam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients
Nancy Levin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results
Simon J. Harrison et al.
CLINICAL CANCER RESEARCH (2016)
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure based virtual screening
Carmen Di Giovanni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Traditional Medicine and Modern Medicine from Natural Products
Haidan Yuan et al.
MOLECULES (2016)
Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
Yoo Seob Shin et al.
PHYTOMEDICINE (2016)
The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase
Tzu-Chin Wu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Heat Shock Proteins Promote Cancer: It's a Protection Racket
Stuart K. Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Molecular targets of gambogic acid in cancer: recent trends and advancements
Dharambir Kashyap et al.
TUMOR BIOLOGY (2016)
The ubiquitin-proteasome system is essential for the productive entry of Japanese encephalitis virus
Shaobo Wang et al.
VIROLOGY (2016)
Suppressive Effects of Tea Catechins on Breast Cancer
Li-Ping Xiang et al.
NUTRIENTS (2016)
Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity
Jianglin Zhang et al.
ONCOTARGET (2016)
Carfilzomib for treating myeloma
Dimitrios C. Ziogas et al.
EXPERT OPINION ON ORPHAN DRUGS (2016)
Proteasome inhibitors Commentary
Beverly A. Teicher et al.
BIOCHEMICAL PHARMACOLOGY (2015)
AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts
Hairong Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Genistein induces apoptosis by stabilizing intracellular p53 protein through an APE1-mediated pathway
Jianwu Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Effect of HDAC-6 on PD cell induced by lactacystin
Li-Fei Xing et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2015)
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Fabrizio Accardi et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro
Jie-yu Xing et al.
PLOS ONE (2015)
Up-Regulatory Effects of Curcumin on Large Conductance Ca2+-Activated K+ Channels
Qijing Chen et al.
PLOS ONE (2015)
Novel Mechanisms of Anticancer Activities of Green Tea Component Epigallocatechin-3-Gallate
Le Zhang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Regulation of proteasome activity in health and disease
Marion Schmidt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors
Isao Momose et al.
CANCER SCIENCE (2014)
Enzyme Inhibition by Hydroamination: Design and Mechanism of a Hybrid Carmaphycin-Syringolin Enone Proteasome Inhibitor
Daniela B. B. Trivella et al.
CHEMISTRY & BIOLOGY (2014)
Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation
Xianping Shi et al.
CLINICAL CANCER RESEARCH (2014)
Natural products: A continuing source of novel drug leads
Gordon M. Cragg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells
Zhiyu Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells
Longyu Jin et al.
ONCOLOGY REPORTS (2013)
Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial Cells
Kazufumi Obata et al.
PLOS ONE (2013)
Syringic acid from Tamarix aucheriana possesses antimitogenic and chemo-sensitizing activities in human colorectal cancer cells
Mohamed-Salah Abaza et al.
PHARMACEUTICAL BIOLOGY (2013)
Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells
Atsushi Sato et al.
STEM CELL RESEARCH (2013)
Gambogic Acid Is a Tissue-Specific Proteasome Inhibitor In Vitro and In Vivo
Xiaofen Li et al.
CELL REPORTS (2013)
Mean 5-Year Clinical and Radiographic Outcomes of Cementless Total Hip Arthroplasty in Patients under the Age of 30
Jeremy M. Gililland et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Anti-cancer Effect and Underlying Mechanism(s) of Kaempferol, a Phytoestrogen, on the Regulation of Apoptosis in Diverse Cancer Cell Models
Seung-Hee Kim et al.
TOXICOLOGICAL RESEARCH (2013)
Proteasome inhibitors in multiple myeloma: 10 years later
Philippe Moreau et al.
BLOOD (2012)
The Carmaphycins: New Proteasome Inhibitors Exhibiting an α,β-Epoxyketone Warhead from a Marine Cyanobacterium
Alban R. Pereira et al.
CHEMBIOCHEM (2012)
Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity
Anja K. Klappan et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2012)
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
Michael Millward et al.
INVESTIGATIONAL NEW DRUGS (2012)
Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin
Wei Liu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Anticancer potential of emodin
Shu-Chun Hsu et al.
BIOMEDICINE-TAIWAN (2012)
Anticancer activity of celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers
Srikumar M. Raja et al.
CANCER BIOLOGY & THERAPY (2011)
A miRNA expression signature that separates between normal and malignant prostate tissues
Jessica Carlsson et al.
CANCER CELL INTERNATIONAL (2011)
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
B. C. Potts et al.
CURRENT CANCER DRUG TARGETS (2011)
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
D. Chen et al.
CURRENT CANCER DRUG TARGETS (2011)
Role of natural product diversity in chemical biology
Jiyong Hong
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Carfilzomib: a novel second-generation proteasome inhibitor
Meaghan L. Khan et al.
FUTURE ONCOLOGY (2011)
Blockade of Her2/neu Binding to Hsp90 by Emodin Azide Methyl Anthraquinone Derivative Induces Proteasomal Degradation of Her2/neu
Yan-yan Yan et al.
MOLECULAR PHARMACEUTICS (2011)
Salinosporamide Natural Products: Potent 20 S Proteasome Inhibitors as Promising Cancer Chemotherapeutics
Tobias A. M. Gulder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia
Anna M. Azarova et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma
Crystal R. Archer et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Aaptamine, an alkaloid from the sponge Aaptos suberitoides, functions as a proteasome inhibitor
Sachiko Tsukamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
Xiufeng Pang et al.
CANCER RESEARCH (2010)
Generating a Generation of Proteasome Inhibitors: From Microbial Fermentation to Total Synthesis of Salinosporamide A (Marizomib) and Other Salinosporamides
Barbara C. Potts et al.
MARINE DRUGS (2010)
Natural Proteasome Inhibitor Celastrol Suppresses Androgen-Independent Prostate Cancer Progression by Modulating Apoptotic Proteins and NF-kappaB
Yao Dai et al.
PLOS ONE (2010)
Synthesis of boronic acid derivatives of tyropeptin: Proteasome inhibitors
Takumi Watanabe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Biosynthesis of the proteasome inhibitor syringolin A: the ureido group joining two amino acids originates from bicarbonate
Christina Ramel et al.
BMC BIOCHEMISTRY (2009)
Pivotal Roles of Snail Inhibition and RKIP Induction by the Proteasome Inhibitor NPI-0052 in Tumor Cell Chemoimmunosensitization
Stavroula Baritaki et al.
CANCER RESEARCH (2009)
Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo
Huanjie Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Genistein Inhibition of Topoisomerase II alpha Expression Participated by Sp1 and Sp3 in HeLa Cell
Najing Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis
Ansgar Bruening et al.
INVESTIGATIONAL NEW DRUGS (2009)
Snapshots of the Fluorosalinosporamide/20S Complex Offer Mechanistic Insights for Fine Tuning Proteasome Inhibition
Michael Groll et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Function-Oriented Biosynthesis of β-Lactone Proteasome Inhibitors in Salinispora tropica
Markus Nett et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells
Ming Chen et al.
MOLECULAR CANCER RESEARCH (2009)
Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine
Mohammad Hossein Mirjalili et al.
MOLECULES (2009)
Cytotoxic Aaptamines from Malaysian Aaptos aaptos
Khozirah Shaari et al.
MARINE DRUGS (2009)
Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage
B-Z Yuan et al.
ONCOGENE (2009)
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
S. Baritaki et al.
ONCOGENE (2009)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo
Vesna Milacic et al.
CANCER RESEARCH (2008)
Leaving Groups Prolong the Duration of 20S Proteasome Inhibition and Enhance the Potency of Salinosporamides
Rama Rao Manam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin
Markus D. Siegelin et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Dynamic Effect of Bortezomib on Nuclear Factor-κB Activity and Gene Expression in Tumor Cells
Myong-Hee Sung et al.
MOLECULAR PHARMACOLOGY (2008)
Natural products to drugs: natural product-derived compounds in clinical trials
Mark S. Butler
NATURAL PRODUCT REPORTS (2008)
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism
Michael Groll et al.
NATURE (2008)
Green tea polyphenols as a natural tumour cell proteasome inhibitor
Q. P. Dou et al.
INFLAMMOPHARMACOLOGY (2008)
Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells
Huanjie Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Inhibition of carcinogenesis by tea constituents
Jihyeung Ju et al.
SEMINARS IN CANCER BIOLOGY (2007)
Kaempferol induces apoptosis in glioblastoma cells through oxidative stress
Vivek Sharma et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures
Xuping Li et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
The tumor proteasome is a primary target for the natural anticancer compound withaferin a isolated from Indian Winter Cherry
Huanjie Yang et al.
MOLECULAR PHARMACOLOGY (2007)
Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome
Katherine A. Reed et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo
Rajesh L. Thangapazham et al.
CANCER LETTERS (2007)
Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells
Di Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis
C. S. Coleman et al.
CELL PROLIFERATION (2006)
NPI-0052 enhances tumoricidal response to conventional cancer therapy in a colon cancer model
James C. Cusack et al.
CLINICAL CANCER RESEARCH (2006)
Prediction of the mechanism of action of omuralide (clasto-lactacystin β-lactone) on human cathepsin A based on a structural model of the yeast proteasome β5/PRE2-subunit/omuralide complex
Sei-ichi Aikawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia
Stacey Ruiz et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Stewart H. Lecker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Celastrol, a triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
Huanjie Yang et al.
CANCER RESEARCH (2006)
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells
ST Nawrocki et al.
CANCER RESEARCH (2005)
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
D Chauhan et al.
CANCER CELL (2005)
The ubiquitin-proteasome pathway and its role in cancer
A Mani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Structure-activity relationship studies of salinosporamide a (NPI-0052), a novel marine derived proteasome inhibitor
VR Macherla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants
KA Bachmann et al.
ANNALS OF PHARMACOTHERAPY (2005)
Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells
D Chen et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells
DJ Kuhn et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through Gαo/i-triggered proteasomal degradation of Rap1GAPII
JD Jordan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
Mario Boccadoro et al.
CANCER CELL INTERNATIONAL (2005)
A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]
WH Lam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor
DJ Kuhn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2004)
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain
R Verma et al.
SCIENCE (2004)
The ubiquitin-proteasome pathway
P Roos-Mattjus et al.
ANNALS OF MEDICINE (2004)
Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action
M Kampa et al.
BREAST CANCER RESEARCH (2004)
The epidemiology of tea consumption and colorectal cancer incidence
L Arab et al.
JOURNAL OF NUTRITION (2003)
Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein
A Kazi et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora
RH Feling et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Inhibition of proteasome activity by tyropeptin A in PC12 cells
I Momose et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2002)
Synthetic analogs of green tea polyphenols as proteasome inhibitors
DM Smith et al.
MOLECULAR MEDICINE (2002)
The proteasome: a novel target for cancer chemotherapy
JB Almond et al.
LEUKEMIA (2002)
Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp MK993-dF2 -: I.: Taxonomy, isolation, physico-chemical properties and biological activities
S Momose et al.
JOURNAL OF ANTIBIOTICS (2001)
Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo
S Nam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
